Year Established :
1952
Total Assets(USD) :
15,000,000 to 19,999,999
Total Number of Staff :
more than 500
Main Competitive Advantages :
Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Small Orders Accepted
Patents and Copyrights :
FDA ;COS; CGMP
Business Type :
Manufacturer,Agent
Annual Turnover(USD) :
More than 1,000,000,000
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Main Product Categorise :
Active Pharmaceutical Ingredients,Intermediates,Excipients
Product Range :
API
Acarbose
Cyclosporine
Mycophenolic acid
Mycophenolate mofetil
Pioglitazone hydrochloride
Pantoprazole sodium
Tacrolimus
Sirolimus(Rapamycin)
Powder of Cordyceps
FORMULATION
Fermented Cordyceps powder
Cyclosporine microem